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Of 193 emergency department workers exposed to
severe acute respiratory syndrome (SARS), 9 (4.7%) were
infected. Pneumonia developed in six workers, and assays
showed anti-SARS immunoglobulin (Ig) M and IgG. The
other three workers were IgM-positive and had lower IgG
titers; in two, mild illness developed, and one remained
asymptomatic.
T
he first case of severe acute respiratory syndrome
(SARS) in Taiwan was reported from the National
Taiwan University Hospital (NTUH) in mid-March 2003
(1). An infected businessman returning from mainland
China was the source of a cluster of infections involving
his family and a physician. Thereafter, a number of spo-
radic cases or small outbreaks emerged in the following
month, mostly imported from abroad. 
A tertiary university medical center in metropolitan
Taipei, NTUH was responsible for most SARS screening
during this time. Many patients with symptoms or signs of
SARS were transferred to the emergency department of
NTUH for evaluation and management. After April 20,
2003, the number of SARS patients increased markedly
because of outbreaks in two hospitals in Taipei. During the
epidemic in Taiwan, >2,000 febrile patients visited the
emergency department of NTUH, and laboratory-con-
firmed SARS was diagnosed in 79 of them. All 79 patients
tested positive for anti-SARS immunoglobulin (Ig) G by
using a commercial immunofluorescent assay (IFA)
(EUROIMMUN Anti-SARS-CoV-IIFT, Lübeck, Ger-
many), and 25 of them also had positive results of reverse
transcriptase–polymerase chain reaction on two separate
respiratory samples (sputum or throat swabs) or one respi-
ratory sample and one nonrespiratory (urine or stool) sam-
ple. After exposure to SARS, fever or diarrhea occurred in
many emergency department workers, and 13 of them
were admitted to the hospital. On May 12, the emergency
department of NTUH was closed; it was reopened on May
26, when all personnel had no indications of disease after
>10 days of isolation. 
The Study
Clinical symptoms and signs (fever, cough, headache,
sore throat, rhinorrhea, and diarrhea), which developed in
the 193 healthcare workers working at the emergency
department of NTUH from March 30 to June 30, were ret-
rospectively evaluated through a formal questionnaire.
Two IFA methods (in-house and EUROIMMUN) for
detecting IgG, IgM, and IgA, and a direct enzyme-linked
immunosorbent assay (ELISA) (SARS-96[TNB], General
Biologicals Corp, Hsin-Chu, Taiwan) for detecting IgG
against the SARS–associated coronavirus (SARS-CoV)
were performed on serum specimens from all of these
workers. For in-house IFA, whole-cell lysate of infected
Vero E6 cells was used as an antigen. Spot slides were pre-
pared by applying the suspension mixed with Vero E6 cells
infected with SARS-CoV (TW1 strain, GenBank acces-
sion no. AY291451) and uninfected cells. Slides were
dried and fixed in acetone. The conjugates used were goat
antihuman IgG, IgM, and IgA conjugated to fluorescein
isothiocyanate (Organon Teknika-Cappel, Turnhout,
Belgium). The starting dilution of serum specimens was
1:25 for the in-house IFA and 1:10 for the EUROIMMUN
kit. Before IgM and IgAwere determined by IFA, antibod-
ies of class IgG were removed from the patient’s serum by
antihuman IgG by using two immunoabsorption kits:
EUROSORB (EUROIMMUN) for commercial IFA and
GULLSORB (Meridian Bioscience Inc., Cincinnati, OH)
for the in-house assay. The cutoff values for a positive
result for IgG, IgM, and IgAwere all 1:25 by in-house IFA
and 1:10 by the commercial IFA kit. IgG against SARS-
CoV by an indirect ELISA was also performed by using
recombinant nucleocapsid as the coated antigen. The cut-
off value of IgG by ELISA was 0.26. 
As control sera, we used 200 paired samples from
patients with community-acquired pneumonia seen at
NTUH from October 2001 to December 2002, 70 serum
samples from hospitalized patients with acute respiratory
distress syndrome treated in 2002 at the hospital, and 10
serum samples obtained from 10 pregnant women during
routine pre-labor check-ups in 2002. All control serum
specimens were negative for IgG by ELISA and IgG, IgM,
or IgA by two IFA methods. 
Reverse transcriptase–polymerase chain reaction (RT-
PCR) assays (nested and real-time) for respiratory speci-
mens (throat swabs and sputum) and serum were
performed for the six workers in whom pneumonia devel-
oped. Cases of laboratory-confirmed SARS in workers
were further classified as asymptomatic, mild, or severe,
according to the criteria provided by the Centers for
Disease Control and Prevention (2).
The 193 workers included 54 men and 139 women,
with a mean age of 32.7 ± 8.2 years. They included 33
physicians, 95 nurses, 17 radiology technicians, 16 clerks,DISPATCHES
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13 sanitation workers, 13 administrative personnel, and 6
ambulance drivers. From March 30 to June 30, 2003, 45
(25.4%) of these workers reported feeling feverish, 51
(26.4%) had cough, 47 (24.4%) had myalgia, 60 (31.6%)
had headache, 54 (28.0%) had sore throat, 41 (21.2%) had
rhinorrhea, and 52 (26.9%) had diarrhea. From May 8 to
May 20, 13 of these workers were consecutively admitted
and isolated; these included 3 physicians, 7 nurses, 2 sani-
tation workers, and 1 clerk. Six (3.1%, 6/193) of these 13
patients, including 3 nurses, 2 sanitation workers, and 1
clerk, met the criteria for severe SARS caused by pneumo-
nia, positive RT-PCR results for respiratory specimens and
serum samples (5 patients), and positive antibody respons-
es. These six patients had a date of disease onset between
May 10 and May 17. They were also positive for IgM and
IgA and had high titers of specific IgG (1:800 to 1:3,200)
against SARS-CoV (Figure part A). The IgG antibody
titers remained high for >150 days after illness onset. Two
of the three physicians (patients A and B) had positive
results for both IgM and IgG, although they both had only
transient fever (38°C for <1 day) and chills without any
respiratory illness (rhinorrhea, sore throat, cough, or dysp-
nea) or gastrointestinal symptoms (nausea, vomiting, or
diarrhea); transient fever developed on May 11 in patient
A and on May 12 in patient B. Their leukocyte and lym-
phocyte counts and liver function were normal. The IgG
antibody titers in these two patients were low (1:25 to
1:100) and disappeared rapidly (52 days and 148 days,
respectively, after onset of illness; Figure part B) com-
pared with those of patients with severe SARS, in whom
IgG is still present as of this writing. RT-PCR studies
(Artus, Roche Diagnostics, Hamburg, Germany) of these
two patients’serum samples were negative for SARS-CoV.
The other five workers who were admitted had negative
antibody results; however, one of them (a nurse) was pos-
itive (1:640) for antibodies against Mycoplasma pneumo-
niae when the particle agglutination method was used.
All but one (an ambulance driver, patient C) of the 180
workers who were not admitted had negative ELISA and
IFA test results on serum samples collected in late June
2003. This worker had normal leukocyte and lymphocyte
counts and did not show any signs or symptoms of respira-
tory illness. However, he had elevated IgM and IgG titers
by IFA, which were both at detectable levels (1:10 and
1:50, respectively) on May 17. The IgM titer remained
positive in serum samples collected on June 9 and then
became negative on June 30 and was still negative on
October 6. Results of RT-PCR studies (Artus, Roche
Diagnostics) of the serum, throat swab, and stool speci-
mens from this patient were negative. 
Overall, the incidence of SARS-CoV infection among
the emergency department workers in this hospital was
4.7% (9/193), including 6 (3.1%) with severe SARS, 2
(1.0%) with mild SARS, and 1 (0.6%) who was asympto-
matic. The incidence of SARS-CoV infection was highest
in ambulance drivers (16.7%), followed by sanitation
workers (15.4%), clerks (6.3%), physicians (6.1%), and
nurses (3.2%). 
Conclusions
This study illustrates three key aspects of the spread of
SARS in an emergency department setting. First, not only
the medical personnel but also the paramedical workers
were at risk for SARS-CoV infection. Although universal
precautions should be strictly followed when staff
encounter patients with a variety of symptoms and signs,
implementing infection-control measures is more difficult
in the emergency department than in the wards or intensive
care units, after patients’ conditions have been identified.
Figure. Changes over time in levels of antibodies against severe
acute respiratory syndrome–associated coronavirus (SARS-CoV)
in patients with laboratory-confirmed SARS. A denotes the
changes in immunoglobulin (Ig) G, IgM, and IgA titers for a repre-
sentative patient with severe SARS. B denotes the changes in IgG
for two patients with mild SARS and one asymptomatic worker
with SARS-CoV infection. The date of illness onset for patient C
was assumed to be May 12, 2003 (the mean date of eight other
SARS patients during the outbreak). SARS and Emergency Department Workers
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In fact, emergency department medical staff members have
been reported to be at a higher risk for infection than staff
members in other hospital departments (3). Second, per-
sons infected with SARS-CoV might manifest only tran-
sient febrile illness and minimal respiratory illness or be
completely free of any clinical symptoms or signs sugges-
tive of SARS. These findings highlight the possibility that
SARS-CoV might produce only mild or asymptomatic
infection, although few previous reports have described
this form of infection with SARS-CoV (4,5).
Finally, patients with mild or asymptomatic SARS-
CoV infection in this study had lower levels (<1:100) of
IgG antibody and earlier seroconversion than those of
patients with severe SARS. This finding partly supports
the hypothesis that an upsurge of antibody response is
associated with increased severity of pulmonary condition
(1). However, Lee et al. reported that a nurse with asymp-
tomatic SARS-CoV infection had an IgG antibody titer as
high as 1:400; IgG titers on the follow-up serum samples
were not reported (4). Li et al. reported two cases of mild
SARS, but antibody titers of these two patients were not
reported (5). Serologic study of serial serum samples from
more persons with mild illness or no symptoms is needed
to confirm our findings of lower levels of IgG and earlier
seroconversion.
Approximately 30% of emergency department workers
without SARS-CoV infection in this study had clinical
symptoms and signs similar to those of SARS during this
epidemic. These illnesses might have been due to influen-
za or other upper airway infections; however, differentiat-
ing between SARS and other respiratory tract infections in
these patients was difficult. 
This study not only highlights the presence of mild and
asymptomatic infection in healthcare workers during a
SARS epidemic but also indicates lower antibody response
and earlier seroconversion. Controlling this highly infec-
tive emerging disease requires meticulous preparation and
vigilance by every worker in the emergency department. 
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